Challenges and Strategies in an Evolving Treatment Paradigm: Pathways for Chronic Lymphocytic Leukemia
WebcastFaculty
OVERVIEW
Challenges and Strategies in an Evolving Treatment Paradigm: Pathways for Chronic Lymphocytic Leukemia is organized by North American Center for Continuing Medical Education (NACCME) and would be held during Oct 20, 2016 - Oct 20, 2017.The Target audience basically for this Event Oncologists.This CME conference has been approved with a maximum of 1.0 AMA PRA Category 1 Credits.
Objectives
•Describe the role of diagnostic testing, staging, biomarkers and prognostic assessment tools in CLL pathway development and their use for informing treatment decisions
•Integrate current and new safety and efficacy data evaluating recently approved agents for CLL into clinical pathways taking into consideration cytogenetic abnormalities, patient age, performance status, and comorbidities
•Discuss strategies to aid in pathway decisions and discussions in the absence of head-to-head trials with novel, targeted CLL agents
•Evaluate current and emerging clinical trial data on novel agents/regimens that may impact the CLL management paradigm
Objectives
•Describe the role of diagnostic testing, staging, biomarkers and prognostic assessment tools in CLL pathway development and their use for informing treatment decisions
•Integrate current and new safety and efficacy data evaluating recently approved agents for CLL into clinical pathways taking into consideration cytogenetic abnormalities, patient age, performance status, and comorbidities
•Discuss strategies to aid in pathway decisions and discussions in the absence of head-to-head trials with novel, targeted CLL agents
•Evaluate current and emerging clinical trial data on novel agents/regimens that may impact the CLL management paradigm
SPECIALITIES
Oncology
Quick Links